Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target.
Knight JS, Meng H, Coit P, Yalavarthi S, Sule G, Gandhi AA, Grenn RC, Mazza LF, Ali RA, Renauer P, Wren JD, Bockenstedt PL, Wang H, Eitzman DT, Sawalha AH.
Knight JS, et al.
JCI Insight. 2017 Sep 21;2(18):e93897. doi: 10.1172/jci.insight.93897. eCollection 2017 Sep 21.
JCI Insight. 2017.
PMID: 28931754
Free PMC article.